Decent Organic Sales Growth Expected for Abbott Laboratories (ABT) in 2026 [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
On January 23, Larry Biegelsen from Wells Fargo maintained an Overweight rating on Abbott Laboratories (NYSE:ABT). However, the analyst lowered the target price on the stock from $146 to $122. Following this, the stock now offers an upside potential of 15% from the current level. Romaset/Shutterstock.com Biegelsen noted some transitory headwinds faced by the business, due to which the company missed consensus sales estimates for the fourth quarter. Although the management has provided guidance of 6.5%-7.5% organic growth in sales during 2026, it still remains below the prior consensus. The analyst attributed these estimates to Nutrition headwinds that are likely to persist during the first half of the year. On January 23, Joanne Wuensch from Citi also reiterated his Buy rating for Abbott Laboratories (NYSE:ABT) and cut his target price from $155 to $140. This revision follows the company's Q4 announcement, and the analyst highlighted the need for improved results going forward
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Late-breaking data presentations showcase the safety and efficacy of Abbott's ablation catheters to treat people with atrial fibrillationPR Newswire
- ?????????????????????????????????????2035????38???????????????????????????(CAGR)?6.11%?????????? [CNET News]CNET News
- Check Your CGM: Recalled FreeStyle Libre 3 Sensors Associated With 7 Deaths [CNET News]CNET News
- Do Wall Street Analysts Like Abbott Laboratories Stock? [Yahoo! Finance]Yahoo! Finance
- AbbVie's (NYSE:ABBV) Q4 CY2025: Beats On Revenue [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 1/22/26 - In-Line
ABT
Sec Filings
- 2/6/26 - Form 4
- 1/26/26 - Form 4
- 1/22/26 - Form 8-K
- ABT's page on the SEC website